16-24931043-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001006634.3(ARHGAP17):āc.2256C>Gā(p.His752Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000932 in 1,609,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001006634.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP17 | NM_001006634.3 | c.2256C>G | p.His752Gln | missense_variant | 19/20 | ENST00000289968.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP17 | ENST00000289968.11 | c.2256C>G | p.His752Gln | missense_variant | 19/20 | 1 | NM_001006634.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152090Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000815 AC: 2AN: 245494Hom.: 0 AF XY: 0.00000755 AC XY: 1AN XY: 132364
GnomAD4 exome AF: 0.00000961 AC: 14AN: 1457260Hom.: 0 Cov.: 32 AF XY: 0.00000828 AC XY: 6AN XY: 724442
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152090Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.2256C>G (p.H752Q) alteration is located in exon 19 (coding exon 19) of the ARHGAP17 gene. This alteration results from a C to G substitution at nucleotide position 2256, causing the histidine (H) at amino acid position 752 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at